Address: Calle 93B No. 16-31 Bogota, D.C., Colombia
Tel: 57-1-654 4444
Novartis De Colombia S.A. want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
Novartis De Colombia S.A. also wants to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.
The current product portfolio includes more than 50 key marketed products, many of which are leaders in their respective therapeutic areas. In 2008, Novartis launched 11 products in the United States and Europe.
The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines we provide to patients, physicians and healthcare organizations. This growing business develops and markets patent-protected prescription drugs for important health needs.
The product development pipeline has 145 projects in various stages of clinical development, including potential new products as well as potential new indications or formulations for existing products.
Cardiovascular and Metabolism, Oncology, Neuroscience and Ophthalmics, Respiratory, Immunology and Infectious Diseases
Being an industry giant with operations in over one hundred counties worldwide, what is the role and significance of Colombia for Novartis global? As a global company, our overall mission…
What is the role, significance, and importance of the Colombian market within the larger global strategy of Genzyme international? Colombia is a very important country because we have a market…
What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all pharmaceutical companies with commercial operations in Latin…
Having just recently celebrated its 50th anniversary in Colombia, how would you describe Farma de Colombia’s unique business model and what have been its keys to its success? We are…
As a promoter and “sales agent” for Bogotá and Colombia can please you take us through the country’s journey over the past decade and how this country, this city have…
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Colombia today is not the Colombia of mainstream Hollywood. Once a country ravaged by domestic insecurity whose images of terror were exported to the rest of the world, the journey…
Mr. Sardi, Exec-VP of Tecnoquímicas, the No. 1 producer and distributor of generic pharmaceutical drugs in Colombia, explains what makes Tecnoquímicas different from their contemporaries and how it grew with…
See our Cookie Privacy Policy Here
